Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1990-6-26
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0038-4348
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
494-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2140467-Hepatitis B,
pubmed-meshheading:2140467-Hepatitis B Vaccines,
pubmed-meshheading:2140467-Humans,
pubmed-meshheading:2140467-Safety,
pubmed-meshheading:2140467-United States,
pubmed-meshheading:2140467-United States Food and Drug Administration,
pubmed-meshheading:2140467-Viral Hepatitis Vaccines
|
pubmed:year |
1990
|
pubmed:articleTitle |
The price of safety.
|
pubmed:publicationType |
Editorial,
Comment
|